Purchase Order 75F40125P00029
Award Date
7/21/25
Potential Completion Date
7/31/25
Potential Value
$2.8K
Federal Agency
Food and Drug Administration
Awardee
Nova Biomedical Corp
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the U.S. Food and Drug Administration (FDA) to Nova Biomedical Corporation, a leading manufacturer of advanced medical equipment and diagnostic devices. The contract, with a ceiling value of $160,625.00, was awarded on August 1, 2016 and has an ultimate completion date of July 31, 2021. The contract is a delivery order under the General Services Administration (GSA) Scientific Equipment and Services schedule (FSS-66) and is a firm fixed-price contract. The...
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Nova Biomedical Corp, a large, privately-owned manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices. The contract, valued at $85,830.50, is for the procurement of BIOPROFILE FLEX2 PARTS AND COMPONENTS - PROCESS ANALYTICAL TECHNOLOGY AND OPTIMIZING INTEGRATION AND AUTOMATED SAMPLING OF ANALYZERS TO BIOREACTOR SYSTEMS. The contract does not have a set-aside...
This is a $23,700.00 firm fixed price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Nova Biomedical Corporation, a leading manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices. The contract is for the delivery of unspecified medical supplies, with a period of performance through May 22, 2024. No set-aside designation was used. Nova Biomedical has an extensive history of federal contract awards, including providing...
This is a $16,900 firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian federal agency, to Nova Biomedical Corp, a leading manufacturer of advanced medical equipment and diagnostic devices. The contract is for the provision of medical supplies with a period of performance through March 26, 2025. Nova Biomedical, a large, privately-owned company headquartered in Waltham, Massachusetts, has a long history of supplying critical medical equipment and...
This is a firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Nova Biomedical Corp, a large for-profit medical equipment manufacturer, for $15,175.92 in medical supplies. The contract has a period of performance ending on February 29, 2024. Nova Biomedical is a leading provider of advanced critical care medical equipment and in-vitro diagnostic devices, including blood gas analyzers, electrolyte testing systems, glucose monitors, and other...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to Nova Biomedical Corp, a manufacturer of advanced critical care blood gas analyzers and other in-vitro diagnostic equipment. The contract is for the procurement of one Nova BioProfile Flex 2 nutrient analyzer and accessories for an existing PacBio Sequel instrument at an FDA facility in Silver Spring, Maryland. The total potential value of the contract is $119,699.00. The original...
This firm-fixed-price purchase order contract, valued at $10,450.00, was awarded by the Bureau of Administration, a civilian federal agency, to Nova Biomedical Corporation, a leading manufacturer of advanced medical equipment and in-vitro diagnostic devices. The contract, which does not have a set-aside designation, is for the provision of unspecified medical supplies with a period of performance ending on November 15, 2024. Nova Biomedical is a large, privately-owned company that has a...
The U.S. government awarded a $23,700.00 firm fixed-price purchase order contract to Nova Biomedical Corp, a leading manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices. The contract, which does not have a set-aside designation, is to provide medical supplies to the Bureau of Administration, a civilian federal agency. The award has an ultimate completion date of June 15, 2024. Nova Biomedical Corp is a large, privately-owned company headquartered in...
This is a firm fixed-price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Nova Biomedical Corp, a leading manufacturer of advanced medical equipment and diagnostic devices. The $15,458.00 contract is for the provision of medical supplies with a completion date of May 22, 2024. The award is not set aside for any special business category. Nova Biomedical is a large, privately-owned company that has a significant track record of providing critical medical...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Nova Biomedical Corp, a manufacturer of advanced medical equipment and supplies. The contract, valued at $196,121.36, is for a standing order of Nova Biomedical's laboratory supplies. The period of performance extends through April 23, 2025. Nova Biomedical Corp is a large, privately-owned in vitro diagnostics company that has a history of providing a wide...